Various methods such as faecal occult blood test (FOBT), colonoscopy, periodic computed tomography (CT), biopsy, and serum carcinoembryonic antigen (CEA) measurement are presently used in CRC screening [6]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.